This specialty practice discussion group is intended for advanced practice professionals of... View more
This specialty practice discussion group is intended for advanced practice professionals of APHON. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
Program Administrator CUMC Minority Underserved NCI Community Oncology Research Program
Columbia University Medical Center
Yes. About three months ago our institution began prescribing daily levaquin for AML and Relapse ALL patients when ANC < 250 and stopping when put on triples or when ANC > 250 if they never became febrile as part of our way to prevent gram negative bacteremia. We discussed with ID as well as other pediatric institutions who also did the same and gathered and evaluated the data before making the change.
—————————— Jessica Edgar CPNP Inpatient PNP, Oncology Phoenix Children’s Hospital Phoenix, Arizona USA ph 623-640-2264 work 602-933-1000 ext 8712 jedgar@ phoenixchildrens.org ——————————